Stock 4569 KYORIN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company KYORIN Pharmaceutical Co., Ltd.

Equities

4569

JP3247090008

Pharmaceuticals

Delayed Japan Exchange
Other stock markets
 07:00:00 27/06/2024 BST 		5-day change 1st Jan Change
1,702 JPY -0.70% Intraday chart for KYORIN Pharmaceutical Co., Ltd. -0.41% -4.38%
2023 ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan MT
2021 KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500 CI

Business Summary

Kyorin Pharmaceutical Co Ltd, formerly Kyorin Holdings Inc, is a Japan-based company mainly engaged in the pharmaceuticals business. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The Company also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.

Number of employees: 2,138

Sales per Business

JPY in Million2023Weight2024Weight Delta
Pharmaceutical
100.0 %
113,270 100.0 % 119,532 100.0 % +5.53%

Sales per region

JPY in Million2023Weight2024Weight Delta
Japan
100.0 %
113,270 100.0 % 119,532 100.0 % +5.53%

Managers

Managers TitleAgeSince
Minoru Hogawa CHM
 Chairman 70 31/12/05
Yutaka Ogihara PSD
 President 56 31/05/11
Yasuyuki Shimokawa CTO
 Chief Tech/Sci/R&D Officer - -
Michiro Onota BRD
 Director/Board Member 63 31/05/19
Yasushi Kurose PRN
 Corporate Officer/Principal - -
Kenji Akutsu AUD
 Comptroller/Controller/Auditor 68 31/03/15
Yoshinobu Hashimoto PRN
 Corporate Officer/Principal - -
Tomiharu Matsumoto AUD
 Comptroller/Controller/Auditor 70 28/02/06

Members of the board

Members of the board TitleAgeSince
Ken Shigematsu BRD
 Director/Board Member 75 31/05/17
Yutaka Ogihara PSD
 President 56 31/05/11
Tomiharu Matsumoto AUD
 Comptroller/Controller/Auditor 70 28/02/06
Minoru Hogawa CHM
 Chairman 70 31/12/05
Noriyuki Shikanai BRD
 Director/Board Member 75 31/05/13
Kenji Akutsu AUD
 Comptroller/Controller/Auditor 68 31/03/15
Michiro Onota BRD
 Director/Board Member 63 31/05/19
Hiromi Watanabe BRD
 Director/Board Member 76 31/05/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 64,607,936 36,933,352 ( 57.17 %) 7,159,000 ( 11.08 %) 57.17 %

Shareholders

NameEquities%Valuation
Ogihara Family
18.05 %
11,660,984 18.05 % 127 M ¥
KYORIN PHARMACEUTICAL CO., LTD.
10.00 %
6,461,800 10.00 % 71 M ¥
Kopernik Global Investors LLC
6.232 %
4,026,400 6.232 % 44 M ¥
Kyorin Group Employee Ownership Plan
3.435 %
2,219,000 3.435 % 24 M ¥
Mariko Ogihara
2.724 %
1,760,000 2.724 % 19 M ¥
KAKEN PHARMACEUTICAL CO., LTD.
2.480 %
1,602,000 2.480 % 17 M ¥
Akira Ogihara
2.467 %
1,594,000 2.467 % 17 M ¥
ONO PHARMACEUTICAL CO., LTD.
1.494 %
965,000 1.494 % 11 M ¥
NISSHIN SEIFUN GROUP INC.
1.167 %
754,000 1.167 % 8 M ¥
KISSEI PHARMACEUTICAL CO., LTD.
1.068 %
690,000 1.068 % 8 M ¥

Holdings

NameEquities%Valuation
KYORIN PHARMACEUTICAL CO., LTD.
10.00%
 6,461,800 10.00% 70,520,790 $
ONO PHARMACEUTICAL CO., LTD.
0.36%
 1,812,000 0.36% 26,232,469 $
KAKEN PHARMACEUTICAL CO., LTD.
1.85%
 852,000 1.85% 19,382,736 $
AIN HOLDINGS INC.
1.13%
 400,000 1.13% 14,890,708 $
NISSHIN SEIFUN GROUP INC.
0.36%
 1,098,075 0.36% 12,312,243 $
TOHO HOLDINGS CO., LTD.
0.49%
 374,980 0.49% 9,475,617 $
KISSEI PHARMACEUTICAL CO., LTD.
0.92%
 454,000 0.92% 9,086,065 $
MEDIPAL HOLDINGS CORPORATION
0.19%
 431,280 0.19% 6,345,220 $
VITAL KSK HOLDINGS, INC.
1.16%
 603,200 1.16% 5,204,995 $
ALFRESA HOLDINGS CORPORATION
0.16%
 319,272 0.16% 4,497,176 $

Company contact information

KYORIN Pharmaceutical Co., Ltd.

4-6 Kanda Surugadai Chiyoda-ku

101-8311, Tokyo

+

http://www.kyorin-gr.co.jp
address KYORIN Pharmaceutical Co., Ltd.(4569)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Ratings for KYORIN Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
1,702 JPY
Average target price
1,300 JPY
Spread / Average Target
-23.62%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
KYORIN PHARMACEUTICAL CO., LTD. Stock KYORIN Pharmaceutical Co., Ltd.
-4.38% 613M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.95% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.62% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.98% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.08% 333B
ABBVIE INC. Stock AbbVie Inc.
+9.05% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.30% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.41% 225B
NOVARTIS AG Stock Novartis AG
+12.47% 218B
AMGEN INC. Stock Amgen Inc.
+8.91% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4569 Stock
  4. Company KYORIN Pharmaceutical Co., Ltd.